Navigation Links
HealthSaaS Inc. with iMPak Health and Meridian Health Announce Integrated Pain Management and Medication Adherence Solution
Date:1/10/2012

PORTLAND, Ore. and NEPTUNE, N.J., Jan. 11, 2012 /PRNewswire-iReach/ -- The iMPak Health Journal for Pain empowers patients to easily record their pain levels before and after their prescribed medication regimen, providing physicians with readily available, useful, patient information.  The Health Journal for Pain provides a consumer engaged method for date and time stamp pain levels and the impact of both long-acting and short medications not readily seen before.

About the size of a smart phone or credit card, iMPak Health products are daily journal device cards that capture health-related data and transmit the information wirelessly using a Near Field Communications (NFC) reader.

Using the HealthSaaS Connected Outcomes Platform patient data will be securely transmitted from a patient's home to health care providers. Physician-requested data can be viewed within graphical reports using HealthSaaS white-labeled provider portals and optionally into backend Electronic Health Record systems (EHRs). Data can also be viewed by patients, family members and caregivers using HealthSaaS patient portals.

"It is widely held that pain is considered the fifth vital sign. The pain journal not only helps track daily pain levels, but is a easy and powerful tool for determining a specific patient's response to their medication regimen," said Sandra Elliott Director of Consumer Technology and Service Development at Meridian Health, a not for profit health system in New Jersey that helped to create iMPak Health.

Frank Ille, CEO, of HealthSaaS said, "We are excited to announce this innovative alliance with iMPak because of the impact that it can make for elderly patients or others that are uncomfortable with computers, or who cannot afford expensive technology. Our collaboration with iMPak focusing on consistent monitoring of pain and medication adherence is an important aspect of any chronic pain management plan. This integrated solution can help improve clinical outcomes, reduce ER visits associated with over/under medicating and will decrease the overall costs associated with managing chronic pain."

"It is clear that both companies share a commitment to making it easy for the patient to engage in their own care," said Albert Baker Director at iMPak Health and VP of Strategic Relations at Cypak a Swedish based technology company that helped create iMPak Health. "A excellent patient experience is fundamental to providing excellent data for a effective outcome focused care system at large."

About HealthSaaS, Inc.
The HealthSaaS Connected Outcomes Platform is a cloud-based system designed to be interoperable with mHealth applications, cloud based services, Telehealth solutions and connected medical devices. This innovative Platform removes silo barriers and makes data available to clinician practices, provider networks, payers, self funded employers and EHR systems.

The HealthSaaS Connected Outcomes Platform is an FDA Class I Medical Device Data System. As an MDDS it is designed and developed in accordance with a quality system compliant with ISO13485 standards so it aligns with the quality requirements of U.S. and international regulatory agencies in the healthcare industry.

For more information, visit www.healthsaas.net


About iMPak Health, L.L.C.
A joint venture of Swedish-based chip developer and innovator Cypak and Meridian Health, a not for profit leader, iMPak Health brings together the latest in wireless technology and the frontline know-how of today's health care environment to provide consumers and patients with effective and intuitive tools to better manage their health.  IMPak Health's mission is to become a leader in developing, easy-to-use devices to screen, diagnose, and monitor health conditions.

For more information, visit www.impakhealth.com or follow us at @seimpakhealth.  



Media Contact: Frank Ille HealthSaaS, Inc., 503-459-9028, frank_ille@healthsaas.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE HealthSaaS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... May 27, 2016 According to ... hypertension is driving ambulatory blood pressure monitoring system market ... and their ability to respond to different pressure rates, ... can lead to various cardiovascular disorders such as heart ... These diseases are growing in prevalence each year. WHO ...
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/27/2016)... The healthcare sector is large ... all falling under its umbrella.  A rather overlooked sector ... talked about, these healthcare companies are still trying to ... is by far the largest consumer of the healthcare ... ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... , ... Psoriasis: Targets and Therapy has published ... author Professor Luigi Naldi says “The review in Psoriasis: Targets and Therapy throws ... onset and the severity of psoriasis, and negatively influences the response to systemic ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... individuals’ genetic characteristics and the physical and behavioral worlds in which they ... In personalized medicine, diagnosing an individual’s disease depends on accurately assessing his ...
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the ... and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside ... of viral hepatitis, the leading cause of liver cancer. , Foundation leaders and the ...
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader in high ... Co., the leading provider of secure mobile remote access solution for Japan enterprises. ... CACHATTO remote access solution. Splashtop for CACHATTO will be available as an ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices to ... this approach has proven transformative, both for people who hear voices and for the ... used around the world, but it still lags in the United States. , Now, ...
Breaking Medicine News(10 mins):